Scotland’s first medicinal cannabis clinic approved to support people with MS and severe epilepsy

Regulators have approved Scotland’s first medical cannabis clinic set to be based in Stirling.

Healthcare Improvement Scotland (HIS) has authorised the Sapphire Medical Clinic, set to provide safe access to medicinal cannabis for patients in Scotland.


In November 2018, medicinal cannabis was legalised in the UK after campaigning showcased the benefits of medicinal cannabis for people with severe epilepsy.

The change in law saw cannabis move from schedule 1 under the Misuse of Drugs Regulations 2001 – meaning it had no therapeutic value – to schedule 2.

“We are delighted to be the first clinic to be registered with HIS, which is a testament to the robust clinical governance framework we have established in evaluating patients for treatment with medical cannabis,” commented Dr Mikael Sodergren, Sapphire Medical’s managing director.

“By capturing clinical outcomes through the UK Medical Cannabis Registry, we will significantly contribute to the evidence base and ultimately allow more patients to benefit from medical cannabis as a treatment option.”


Campaigners calling for access to medicinal cannabis include people living with multiple sclerosis (MS) and the parents of children with severe epilepsy.

At present, virtual appointments will be in place for clients with plans to introduce face-to-face assessments when COVID-19 restrictions allow.

In reference to prescribing medicinal cannabis, the Scottish Government has said it has no influence and prescription decisions lie with specialist clinicians.

The opening of the first medicinal cannabis clinic has been celebrated.

Get the latest news by following Enable on social media, TwitterFacebook or Instagram.

Accessibility Tools

Discover more from Enable Magazine

Subscribe now to keep reading and get access to the full archive.

Continue reading